A. G. Prentice

4.6k citations

68 papers · 3.3k indexed · h-index 29

Hematology top 1%
- Acute Myeloid Leukemia Research 12
Reproductive Medicine top 1%
- Ovarian function and disorders 5
Genetics top 1%
- Chronic Lymphocytic Leukemia Research 17
Obstetrics and Gynecology top 2%
Immunology top 5%
Infectious Diseases
- Antifungal resistance and susceptibility 15
Epidemiology
- Fungal Infections and Studies 10
Oncology
- Neutropenia and Cancer Infections 8
- Cancer-related Molecular Pathways 6
Pathology and Forensic Medicine
- Lymphoma Diagnosis and Treatment 6

Co-authors: Axel Glasmacher J. McLaren D. Stephen Charnock‐Jones S. K. Smith Andrew Sharkey J. A. Copplestone Karin H. Müller Keith Wheatley
Cited by: Hematology Reproductive Medicine Genetics
Journals: Blood (12 papers)British Journal of Haematology (8 papers)Journal of Antimicrobial Chemotherapy (6 papers)
Partner nations: United Kingdom United States Germany

In The Last Decade

A. G. Prentice

67 papers receiving 3.2k citations

Peers

Countries citing papers authored by A. G. Prentice

Since Specialization

Citations

This map shows the geographic impact of A. G. Prentice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. G. Prentice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. G. Prentice more than expected).

Fields of papers citing papers by A. G. Prentice

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. G. Prentice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. G. Prentice. The network helps show where A. G. Prentice may publish in the future.

Co-authorship network

The 25 scholars most cited alongside A. G. Prentice, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. G. Prentice Line = papers co-authored together A. G. Prentice links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis BMC Medicine ·Simone Lanini,Aoife Molloy,Paul Fine,A. G. Prentice,Giuseppe Ippolito,Christopher C. Kibbler	2011	74
2	Aberrantly activated anti‐apoptotic signalling mechanisms in chronic lymphocytic leukaemia cells: clues to the identification of novel therapeutic targets British Journal of Haematology ·R. Gitendra Wickremasinghe,A. G. Prentice,Andrew J. Steele	2011	16
3	The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial British Journal of Haematology ·Alan K. Burnett,Donald Milligan,Anthony P. Goldstone,A. G. Prentice,Mary‐Frances McMullin,Michael Dennis,Qian Zhang,Monica Pallis,Nigel H. Russell,Robert K. Hills,Keith Wheatley	2009	110
4	The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro Leukemia ·Andrew J. Steele,Dylan T. Jones,K. Ganeshaguru,Veronique Duke,Hiroshi Haga,Janet North,Mark W. Lowdell,PD Kottaridis,Atul Mehta,A. G. Prentice,A. V. Hoffbrand,R G Wickremasinghe	2006	63
5	Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies Journal of Antimicrobial Chemotherapy ·Axel Glasmacher,A. G. Prentice	2005	38
6	An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients Clinical Microbiology and Infection ·Axel Glasmacher,M von Lilienfeld-Toal,سماحية دايم,Christian Hahn,Ingo G.H. Schmidt‐Wolf,A. G. Prentice	2005	49
7	Attempts to modulate chemoresistance in older patients with AML using PSC-833 - Results of the LRF AML14 trial Blood ·Alan K. Burnett,Robert K. Hills,A H Goldstone,A. G. Prentice,Don Milligan,Monica Pallis,Nigel H. Russell,Juan Antono Carrllo,Keith Wheatley	2003	4
8	Oral antifungals as prophylaxis in haematological malignancy Blood Reviews ·A. G. Prentice,Peter Donnelly	2001	11
9	Ultrasound criteria in the diagnosis of polycystic ovary syndrome (PCOS) Ultrasound in Medicine & Biology ·William Atiomo,Sally‐Ann Pearson,Steve Shaw,A. G. Prentice,Paul A. Dubbins	2000	53
10	Immunohistochemical detection of plasminogen activator inhibitor-1 in polycystic ovaries Gynecological Endocrinology ·William Atiomo,D. A. Hilton,R. Fox,Ramírez G. Gustavo Antonio,Steve Shaw,John Friend,Terence J. Wilkin,A. G. Prentice	2000	15
11	The plasminogen activator system in women with polycystic ovary syndrome Fertility and Sterility ·William Atiomo,О.Д. Авраамова,Fábio Fernandes,Steve Shaw,Fernando Eduardo Cano Legua,A. G. Prentice	1998	105
12	Immunolocalization of the apoptosis regulating proteins Bcl-2 and Bax in human endometrium and isolated peritoneal fluid macrophages in endometriosis Human Reproduction ·J. McLaren,A. G. Prentice,D. Stephen Charnock‐Jones,Andrew Sharkey,S. K. Smith	1997	82
13	Fungal infections: a survey of laboratory services for diagnosis and treatment. PubMed ·Rosemary A. Barnes,David W. Denning,E. G. V. Evans,R. J. Hay,C Kibbler,A. G. Prentice,Malcolm Richardson,JoAnne M. Breslin,Thomas R. Rogers,D. C. E. Speller,David W. Warnock,Richard Warren	1996	11
14	Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. Journal of Clinical Investigation ·J. McLaren,A. G. Prentice,D. Stephen Charnock‐Jones,Jei Q. Pastrana,Karin H. Müller,Andrew Sharkey,S. K. Smith	1996	420
15	Mitoxantrone, Chlorambucil and Prednisolone in the Treatment of Non-Hodgkin's Lymphoma Leukemia & lymphoma ·Meghashree Hajong,Stephen A. Johnson,A. G. Prentice,Lydia Jones,M. J. Phillips,Adrian C. Newland	1994	4
16	Comparison of the multiple dose pharmacokinetics of two formulations of itraconazole during remission induction for acute myeloblastic leukaemia Journal of Antimicrobial Chemotherapy ·Carol R. Bradford,A. G. Prentice,David W. Warnock,J. A. Copplestone	1991	39
17	Clonal Evolution in Ph-Negative, bcr-Positive Chronic Myeloid Leukaemia before and after Bone Marrow Transplantation Acta Haematologica ·Lorna M. Secker‐Walker,H.M. Cooke,Peter Browett,John D. Norton,J Ruggiero,A. G. Prentice,賢一西沢	1989	3
18	Meningeal relapse in Ph1-positive acute lymphoblastic and lymphoid blast crisis of chronic granulocytic leukemia. Is CNS-prophylaxis indicated? Cancer ·Alastair G. Smith,A. G. Prentice,N.P. Lucie,J. H. Dagg	1983	5
19	Red cell hypoplasia due to azathioprine following renal transplantation Clinical & Laboratory Haematology ·A. G. Prentice,Gerald A. Young,Yasushi SUGIYAMA,D. Škopljanac-Mačina,J. D. Briggs	1980	1
20	Christmas Disease (Clotting Factor IX Deficiency) and the Presentation of a Carcinoid Tumour in an Inguinal Hernia International Journal of Clinical Practice ·A. G. Prentice	1980	1

About A. G. Prentice

A. G. Prentice is a scholar working on Genetics, Hematology and Reproductive Medicine, having authored 68 papers that have together received 3.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (17 papers), Antifungal resistance and susceptibility (15 papers), Acute Myeloid Leukemia Research (12 papers), Fungal Infections and Studies (10 papers), Neutropenia and Cancer Infections (8 papers), Cancer-related Molecular Pathways (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Ovarian function and disorders (5 papers). The work is most often cited by research in Hematology (968 citations), Reproductive Medicine (627 citations) and Genetics (730 citations). A. G. Prentice has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Axel Glasmacher, J. McLaren, D. Stephen Charnock‐Jones, S. K. Smith, Andrew Sharkey, J. A. Copplestone, Karin H. Müller, Keith Wheatley, Donald Milligan and David W. Warnock. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Antimicrobial Chemotherapy, Journal of Clinical Oncology and Journal of Clinical Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact